179 related articles for article (PubMed ID: 34944008)
1. Alterations in SLC4A2, SLC26A7 and SLC26A9 Drive Acid-Base Imbalance in Gastric Neuroendocrine Tumors and Uncover a Novel Mechanism for a Co-Occurring Polyautoimmune Scenario.
Calvete O; Reyes J; Valdés-Socin H; Martin P; Marazuela M; Barroso A; Escalada J; Castells A; Torres-Ruiz R; Rodríguez-Perales S; Currás-Freixes M; Benítez J
Cells; 2021 Dec; 10(12):. PubMed ID: 34944008
[TBL] [Abstract][Full Text] [Related]
2. A genetic origin for acid-base imbalance triggers the mitochondrial damage that explains the autoimmune response and drives to gastric neuroendocrine tumours.
Benítez J; Marra R; Reyes J; Calvete O
Gastric Cancer; 2020 Jan; 23(1):52-63. PubMed ID: 31250150
[TBL] [Abstract][Full Text] [Related]
3. A cumulative effect involving malfunction of the PTH1R and ATP4A genes explains a familial gastric neuroendocrine tumor with hypothyroidism and arthritis.
Calvete O; Herraiz M; Reyes J; Patiño A; Benitez J
Gastric Cancer; 2017 Nov; 20(6):998-1003. PubMed ID: 28474257
[TBL] [Abstract][Full Text] [Related]
4. Case Report: CMV Infection and Same Mechanism-Originated Intestinal Inflammation Compatible With Bowel/Crohn's Disease Is Suggested in ATP4A Mutated-Driven Gastric Neuroendocrine Tumors.
Calvete O; Reyes J; Benítez J
Front Med (Lausanne); 2021; 8():553110. PubMed ID: 33889580
[TBL] [Abstract][Full Text] [Related]
5. Exome sequencing identifies ATP4A gene as responsible of an atypical familial type I gastric neuroendocrine tumour.
Calvete O; Reyes J; Zuñiga S; Paumard-Hernández B; Fernández V; Bujanda L; Rodriguez-Pinilla MS; Palacios J; Heine-Suñer D; Banka S; Newman WG; Cañamero M; Pritchard DM; Benítez J
Hum Mol Genet; 2015 May; 24(10):2914-22. PubMed ID: 25678551
[TBL] [Abstract][Full Text] [Related]
6. SLC26A9 deficiency causes gastric intraepithelial neoplasia in mice and aggressive gastric cancer in humans.
Liu X; Li T; Ma Z; Riederer B; Yuan D; Zhu J; Li Y; An J; Wen G; Jin H; Yang X; Seidler U; Tuo B
Cell Oncol (Dordr); 2022 Jun; 45(3):381-398. PubMed ID: 35426084
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic ATM Variant-Harbouring Well-Differentiated Aggressive Type 1 Gastric Neuroendocrine Tumour with High-grade Features (G3 NET): a New Addition to the Clinical and Pathological Spectrum of Gastric Neuroendocrine Neoplasms.
Nassereddine H; Chicaud M; Rebah K; Théou-Anton N; Sautet A; Dermer J; Couvelard A
Endocr Pathol; 2021 Dec; 32(4):517-523. PubMed ID: 34019237
[TBL] [Abstract][Full Text] [Related]
8. A knockin mouse model for human ATP4aR703C mutation identified in familial gastric neuroendocrine tumors recapitulates the premalignant condition of the human disease and suggests new therapeutic strategies.
Calvete O; Varro A; Pritchard DM; Barroso A; Oteo M; Morcillo MÁ; Vargiu P; Dodd S; Garcia M; Reyes J; Ortega S; Benitez J
Dis Model Mech; 2016 Sep; 9(9):975-84. PubMed ID: 27491072
[TBL] [Abstract][Full Text] [Related]
9. Regulation of solute carrier family 26 member 7 (Slc26a7) by thyroid stimulating hormone in thyrocytes.
Tanimura Y; Kiriya M; Kawashima A; Mori H; Luo Y; Kondo T; Suzuki K
Endocr J; 2021 Jun; 68(6):691-699. PubMed ID: 33583874
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune polyendocrine syndromes.
Cutolo M
Autoimmun Rev; 2014 Feb; 13(2):85-9. PubMed ID: 24055063
[TBL] [Abstract][Full Text] [Related]
11. Chloride/bicarbonate exchanger SLC26A7 is localized in endosomes in medullary collecting duct cells and is targeted to the basolateral membrane in hypertonicity and potassium depletion.
Xu J; Worrell RT; Li HC; Barone SL; Petrovic S; Amlal H; Soleimani M
J Am Soc Nephrol; 2006 Apr; 17(4):956-67. PubMed ID: 16524946
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use.
Parsons BN; Ijaz UZ; D'Amore R; Burkitt MD; Eccles R; Lenzi L; Duckworth CA; Moore AR; Tiszlavicz L; Varro A; Hall N; Pritchard DM
PLoS Pathog; 2017 Nov; 13(11):e1006653. PubMed ID: 29095917
[TBL] [Abstract][Full Text] [Related]
13. SLC26A7 is a Cl- channel regulated by intracellular pH.
Kim KH; Shcheynikov N; Wang Y; Muallem S
J Biol Chem; 2005 Feb; 280(8):6463-70. PubMed ID: 15591059
[TBL] [Abstract][Full Text] [Related]
14. [Autoimmune metaplastic atrophic gastritis, G cell hyperplasia and neuroendocrine tumor of stomach].
Chen G; Huang S
Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):34-5. PubMed ID: 24713247
[No Abstract] [Full Text] [Related]
15. Enterochromaffin-like Cell Hyperplasia-Associated Gastric Neuroendocrine Tumors May Arise in the Setting of Proton Pump Inhibitor Use.
Rais R; Trikalinos NA; Liu J; Chatterjee D
Arch Pathol Lab Med; 2022 Mar; 146(3):366-371. PubMed ID: 34283890
[TBL] [Abstract][Full Text] [Related]
16. Factors related to gastric neuroendocrine tumors.
Soto-Solís R; Romano-Munive AF; Santana de Anda K; Barreto-Zuñiga R
Rev Gastroenterol Mex (Engl Ed); 2019; 84(1):52-56. PubMed ID: 29705524
[TBL] [Abstract][Full Text] [Related]
17. [Endoscopic treatment for gastric carcinoid tumor in a patient with type A gastritis complicated with autoimmune polyendocrine syndrome: a case report].
Mie T; Ohta T; Iwamoto T; Mizumoto R; Arimoto Y; Toda M; Shimizu S; Yamaguchi S; Ito Y; Hagiwara H
Nihon Shokakibyo Gakkai Zasshi; 2019; 116(8):654-659. PubMed ID: 31406070
[TBL] [Abstract][Full Text] [Related]
18. The Morphologic Spectrum of Gastric Type 1 Enterochromaffin-Like Cell Neuroendocrine Tumors.
Poveda JC; Chahar S; Garcia-Buitrago MT; Montgomery EA; McDonald OG
Mod Pathol; 2023 Apr; 36(4):100098. PubMed ID: 36913909
[TBL] [Abstract][Full Text] [Related]
19. The iodide transporter Slc26a7 impacts thyroid function more strongly than Slc26a4 in mice.
Yamaguchi N; Suzuki A; Yoshida A; Tanaka T; Aoyama K; Oishi H; Hara Y; Ogi T; Amano I; Kameo S; Koibuchi N; Shibata Y; Ugawa S; Mizuno H; Saitoh S
Sci Rep; 2022 Jul; 12(1):11259. PubMed ID: 35788623
[TBL] [Abstract][Full Text] [Related]
20. Impaired salivary gland activity in patients with autoimmune polyendocrine syndrome type I.
Oftedal BE; Marthinussen MC; Erichsen MM; Tveitarås MK; Kjellesvik-Kristiansen A; Hammenfors D; Jonsson MV; Kisand K; Jonsson R; Wolff ASB
Autoimmunity; 2017 Jun; 50(4):211-222. PubMed ID: 28686485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
